Cefoperazone and cefoxitin prophylaxis for abdominal hysterectomy

D. L. Hemsell, E. R. Johnson, R. E. Bawdon, P. G. Hemsell, M. L. Heard, B. J. Nobles

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

One hundred one women undergoing elective abdominal hysterectomy were given perioperative cefoperazone or cefoxitin in a prospective randomized blinded study. Both regimens were well tolerated and no significant toxic or allergic manifestations were observed. Interrelationships between antimicrobial concentration in serum and pelvic tissues, intraoperative cardinal ligament cultures, febrile morbidity, and major postoperative infection were determined. At uterine removal, mean cefoperazone concentrations in serum (56.1 μg/mL) and pelvic tissues (18.6 μg/g) were significantly higher than mean concentrations of cefoxitin, ie, 16.1 μg/mL and 8.1 μg/g, respectively (P < .001). The incidence of major postoperative infection was 6% or less with both regimens. Perioperative prophylaxis significantly reduced the incidence of this infection. When it did develop, however, it continued to cause significant morbidity, prolonging hospital stay a mean of more than four days (P < .001) and increasing the hospital bill a mean of almost $1500 (P < .001).

Original languageEnglish (US)
Pages (from-to)467-472
Number of pages6
JournalObstetrics and Gynecology
Volume63
Issue number4
StatePublished - 1984

Fingerprint

Cefoperazone
Cefoxitin
Hysterectomy
Infection
Morbidity
Poisons
Incidence
Serum
Ligaments
Length of Stay
Fever

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Hemsell, D. L., Johnson, E. R., Bawdon, R. E., Hemsell, P. G., Heard, M. L., & Nobles, B. J. (1984). Cefoperazone and cefoxitin prophylaxis for abdominal hysterectomy. Obstetrics and Gynecology, 63(4), 467-472.

Cefoperazone and cefoxitin prophylaxis for abdominal hysterectomy. / Hemsell, D. L.; Johnson, E. R.; Bawdon, R. E.; Hemsell, P. G.; Heard, M. L.; Nobles, B. J.

In: Obstetrics and Gynecology, Vol. 63, No. 4, 1984, p. 467-472.

Research output: Contribution to journalArticle

Hemsell, DL, Johnson, ER, Bawdon, RE, Hemsell, PG, Heard, ML & Nobles, BJ 1984, 'Cefoperazone and cefoxitin prophylaxis for abdominal hysterectomy', Obstetrics and Gynecology, vol. 63, no. 4, pp. 467-472.
Hemsell DL, Johnson ER, Bawdon RE, Hemsell PG, Heard ML, Nobles BJ. Cefoperazone and cefoxitin prophylaxis for abdominal hysterectomy. Obstetrics and Gynecology. 1984;63(4):467-472.
Hemsell, D. L. ; Johnson, E. R. ; Bawdon, R. E. ; Hemsell, P. G. ; Heard, M. L. ; Nobles, B. J. / Cefoperazone and cefoxitin prophylaxis for abdominal hysterectomy. In: Obstetrics and Gynecology. 1984 ; Vol. 63, No. 4. pp. 467-472.
@article{cedcd339cc92412ab4a3a6a7bbdb66a2,
title = "Cefoperazone and cefoxitin prophylaxis for abdominal hysterectomy",
abstract = "One hundred one women undergoing elective abdominal hysterectomy were given perioperative cefoperazone or cefoxitin in a prospective randomized blinded study. Both regimens were well tolerated and no significant toxic or allergic manifestations were observed. Interrelationships between antimicrobial concentration in serum and pelvic tissues, intraoperative cardinal ligament cultures, febrile morbidity, and major postoperative infection were determined. At uterine removal, mean cefoperazone concentrations in serum (56.1 μg/mL) and pelvic tissues (18.6 μg/g) were significantly higher than mean concentrations of cefoxitin, ie, 16.1 μg/mL and 8.1 μg/g, respectively (P < .001). The incidence of major postoperative infection was 6{\%} or less with both regimens. Perioperative prophylaxis significantly reduced the incidence of this infection. When it did develop, however, it continued to cause significant morbidity, prolonging hospital stay a mean of more than four days (P < .001) and increasing the hospital bill a mean of almost $1500 (P < .001).",
author = "Hemsell, {D. L.} and Johnson, {E. R.} and Bawdon, {R. E.} and Hemsell, {P. G.} and Heard, {M. L.} and Nobles, {B. J.}",
year = "1984",
language = "English (US)",
volume = "63",
pages = "467--472",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Cefoperazone and cefoxitin prophylaxis for abdominal hysterectomy

AU - Hemsell, D. L.

AU - Johnson, E. R.

AU - Bawdon, R. E.

AU - Hemsell, P. G.

AU - Heard, M. L.

AU - Nobles, B. J.

PY - 1984

Y1 - 1984

N2 - One hundred one women undergoing elective abdominal hysterectomy were given perioperative cefoperazone or cefoxitin in a prospective randomized blinded study. Both regimens were well tolerated and no significant toxic or allergic manifestations were observed. Interrelationships between antimicrobial concentration in serum and pelvic tissues, intraoperative cardinal ligament cultures, febrile morbidity, and major postoperative infection were determined. At uterine removal, mean cefoperazone concentrations in serum (56.1 μg/mL) and pelvic tissues (18.6 μg/g) were significantly higher than mean concentrations of cefoxitin, ie, 16.1 μg/mL and 8.1 μg/g, respectively (P < .001). The incidence of major postoperative infection was 6% or less with both regimens. Perioperative prophylaxis significantly reduced the incidence of this infection. When it did develop, however, it continued to cause significant morbidity, prolonging hospital stay a mean of more than four days (P < .001) and increasing the hospital bill a mean of almost $1500 (P < .001).

AB - One hundred one women undergoing elective abdominal hysterectomy were given perioperative cefoperazone or cefoxitin in a prospective randomized blinded study. Both regimens were well tolerated and no significant toxic or allergic manifestations were observed. Interrelationships between antimicrobial concentration in serum and pelvic tissues, intraoperative cardinal ligament cultures, febrile morbidity, and major postoperative infection were determined. At uterine removal, mean cefoperazone concentrations in serum (56.1 μg/mL) and pelvic tissues (18.6 μg/g) were significantly higher than mean concentrations of cefoxitin, ie, 16.1 μg/mL and 8.1 μg/g, respectively (P < .001). The incidence of major postoperative infection was 6% or less with both regimens. Perioperative prophylaxis significantly reduced the incidence of this infection. When it did develop, however, it continued to cause significant morbidity, prolonging hospital stay a mean of more than four days (P < .001) and increasing the hospital bill a mean of almost $1500 (P < .001).

UR - http://www.scopus.com/inward/record.url?scp=0021352667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021352667&partnerID=8YFLogxK

M3 - Article

C2 - 6366664

AN - SCOPUS:0021352667

VL - 63

SP - 467

EP - 472

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 4

ER -